Skip to main navigation menu Skip to main content Skip to site footer

Characterization of patients with thrombocytopenia in a third level of complexity institution in Medellin, Colombia.

Caracterización de pacientes con trombocitopenia en una institución de tercer nivel de complejidad Medellín, Colombia.




Section
Artículos de Investigación

How to Cite
Vergara Yanez, D., Martínez-Sanchez, L. M., Hernández-Martínez, A., Roldan-Tabares, M. D., Herrera-Almanza, L., Villegas-Alzate, . J. D. ., Calle-Estrada, M. C., & Aristizábal-Hernández, J. J. (2022). Characterization of patients with thrombocytopenia in a third level of complexity institution in Medellin, Colombia . Archivos De Medicina , 22(2). https://doi.org/10.30554/archmed.22.2.4354.2022
Download Citation

Dimensions
PlumX

How to Cite

Vergara Yanez, D., Martínez-Sanchez, L. M., Hernández-Martínez, A., Roldan-Tabares, M. D., Herrera-Almanza, L., Villegas-Alzate, . J. D. ., Calle-Estrada, M. C., & Aristizábal-Hernández, J. J. (2022). Characterization of patients with thrombocytopenia in a third level of complexity institution in Medellin, Colombia . Archivos De Medicina , 22(2). https://doi.org/10.30554/archmed.22.2.4354.2022

Download Citation

Daniela Vergara Yanez
Lina María Martínez-Sanchez
Alejandro Hernández-Martínez
Mabel Dahiana Roldan-Tabares
Laura Herrera-Almanza
Juan Diego Villegas-Alzate
María Camila Calle-Estrada
José Julián Aristizábal-Hernández

Objective: characterize patients with thrombocytopenia in a third level-of-complexity institution in Medellín, Colombia. Materials and methods: a retrospective descriptive study was carried out, which included all patients with thrombocytopenia-related diagnosis treated in a level-of-complexity institution in the city of Medellin, during the January 2016 to December 2017-time period. A non-probabilistic sampling of consecutive cases was done. Results: 25 patients with thrombocytopenia were included. 80% of them (20) corresponded to children under 1 year of age and 20% (5) to people over 18 years of age, 52% (13) were male. Median in-hospital stay for adults was 10 days with a P25 of 5 and P75 of 39, for those aged <1 year, it was 32 (P25: 15 and P75: 53,25). 80% (20) of the patients were classified with unspecified thrombocytopenia, the remaining 20% (5) with secondary thrombocytopenia. The platelet counts in adults had a median of 95.000 cells/mm3 (P25: 67.000 and P75: 122.00) and in <1 year the median was 79.000 cells/mm3 (P25: 53.750 and P75: 109.750). Conclusions: thrombocytopenia was more common in children under 1 year and in the male sex, requiring longer hospital stays. Thrombocytopenia for both groups was classified as mild and according to its diagnosis as unspecified.


Article visits 268 | PDF visits 166


Downloads

Download data is not yet available.
  1. Lee EJ, Lee AI. Thrombocytopenia. Prim Care. 2016;43(4):543-557. DOI: 10.1016/j.pop.2016.07.008
  2. Fountain EM, Arepally GM. Etiology and complications of thrombocytopenia in hospitalized medical patients. J Thromb Thrombolysis. 2017;43(4):429-436. DOI: 10.1007/s11239-016-1467-8.
  3. Gauer RL, Braun MM. Thrombocytopenia. Am Fam Physician. 2012;85(6):612-22.
  4. Akca S, Haji-Michael P, de Mendonça A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med. 2002;30(4):753-756. DOI:10.1097/00003246-200204000-00005
  5. Crowther MA, Cook DJ, Meade MO, Griffith LE, Guyatt GH, Arnold DM, et al. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care. 2005;20(4):348-353. DOI: 10.1016/j.jcrc.2005.09.008
  6. Greenberg EM. Thrombocytopenia: A Destruction of Platelets. J Infus Nurs. 2017;40(1):41-50. DOI:10.1097/NAN.0000000000000204
  7. Nandyal S, Shashikala P, Sahgal V. Study of thrombocytopenia in neonatal intensive care unit. IJPO. 2016;3(1);55-59
  8. Khalessi N, Khosravi N, Sanii S, Zareh Mehrjerdi F. The Prevalence and Risk Factors for Neonatal Thrombocytopenia among Newborns Admitted to Intensive Care Unit of Aliasghar Children’s Hospital. IJBC. 2013;2: 41-45
  9. Jeremiah Z, Oburu J. Pattern and prevalence of neonatal thrombocytopenia in Port Harcourt, Nigeria. Pathology and Laboratory Medicine International. 2010; 2:27-31
  10. Beiner ME, Simchen MJ, Sivan E, Chetrit A, Kuint J, Schiff E. Risk Factors for Neonatal Thrombocytopenia in Preterm Infants. Am. J. Perinatol. 2003:20(1); 49-54
  11. Bolat F, Kılıç SÇ, Oflaz MB, Gülhan E, Kaya A, Güven AS, et al. The prevalence and outcomes of thrombocytopenia in a neonatal intensive care unit: a three-year report. Pediatr Hematol Oncol. 2012;29(8):710-720. DOI:10.3109/08880018.2012.725454
  12. Vaughan JL, Fourie J, Naidoo S, Subramony N, Wiggill T, Alli N. Prevalence and causes of thrombocytopenia in an academic state-sector laboratory in Soweto, Johannesburg, South Africa. S Afr Med J. 2015;105(3):215-219. DOI:10.7196/samj.8791
  13. Shalansky SJ, Verma AK, Levine M, Spinelli JJ, Dodek PM. Risk markers for thrombocytopenia in critically ill patients: a prospective analysis. Pharmacotherapy. 2002;22(7):803-813. DOI:10.1592/phco.22.11.803.33634
  14. Crespo EM, Oliveira GB, Honeycutt EF, Backer RC, Berger PB, Moliterno DJ et al. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J. 2009;157(4):651-657. DOI: 10.1016/j.ahj.2009.01.005
  15. Venkata C, Kashyap R, Farmer JC, Afessa B. Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome. J Intensive Care. 2013;1(1):9. DOI:10.1186/2052-0492-1-9
Sistema OJS 3.4.0.10 - Metabiblioteca |